Literature DB >> 30592648

Important decisions in choosing the pharmacotherapy for narcoleptics.

Stefano de Biase1, Gian Luigi Gigli1,2, Mariarosaria Valente1,3.   

Abstract

Keywords:  Cataplexy; excessive daytime sleepiness; hypocretin; investigational drugs; modafinil; narcolepsy; pitolisant; sodium oxybate

Year:  2018        PMID： 30592648     DOI： 10.1080/14656566.2018.1561861

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN： 1465-6566            Impact factor:   3.889


× No keyword cloud information.
  3 in total

1.  Effects of Pharmacotherapy Treatment on Patient-Reported Outcomes in a Narcolepsy and Idiopathic Hypersomnia Cohort.

Authors:  Maeve Pascoe; James Bena; Nancy Foldvary-Schaefer
Journal:  J Clin Sleep Med       Date:  2019-10-30       Impact factor: 4.062

Review 2.  Pitolisant: A Review in Narcolepsy with or without Cataplexy.

Authors:  Yvette N Lamb
Journal:  CNS Drugs       Date:  2020-02       Impact factor: 5.749

Review 3.  Pitolisant to Treat Excessive Daytime Sleepiness and Cataplexy in Adults with Narcolepsy: Rationale and Clinical Utility.

Authors:  Jay T Guevarra; Robert Hiensch; Andrew W Varga; David M Rapoport
Journal:  Nat Sci Sleep       Date:  2020-10-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.